Edition:
United Kingdom

People: Achillion Pharmaceuticals Inc (ACHN.OQ)

ACHN.OQ on NASDAQ Stock Exchange Global Select Market

4.65USD
19 Aug 2019
Change (% chg)

-- (--)
Prev Close
$4.65
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
420,558
52-wk High
$5.02
52-wk Low
$1.29

Di Donato, Brian 

Mr. Brian Di Donato is Chief Financial Officer, Senior Vice President, Treasurer of the Company. Mr. Di Donato is an experienced capital markets banker, investor and fund manager, having previously held positions as Managing Director and Co-Portfolio Manager at Sorin Capital Management and President and Chief Investment Officer at Capmark Investments. He previously worked in fixed-income capital markets as an Executive Director at Morgan Stanley and Vice President at UBS Securities. Mr. Di Donato holds a Master of Business Administration from New York University's Stern School of Business as well as bachelors of science degrees in biology from Penn State University and in mechanical engineering from Villanova University. Prior to business school, he was an aerospace engineering officer in the U.S. Navy.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --